SCHEMBL29901062

SCHEMBL29901062

Cc1ccc(CC(C)(C)C(=O)O)cc1CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CYP2C9 P11712 3/20 0.42
▸ LMNA P02545 2/20 0.41
▸ PPARA Q07869 3/20 0.41
▸ SLC22A12 Q96S37 2/20 0.41
▸ CYP1A2 P05177 4/20 0.41
▸ TDP1 Q9NUW8 4/20 0.41
▸ HPGD P15428 4/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ ADRA1A P35348 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ BLM P54132 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ EGFR P00533 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24042028 0.83 PPARA (0.36) CYP2C9PPARAHPGDMAPTPOLB
SCHEMBL24226063 0.80 ESR1 (0.47) KDM4ECYP1A2TDP1HPGDCYP3A4
SCHEMBL29442667 0.78 KDM4E (0.41) KDM4EL3MBTL1CYP2C9LMNAPPARA
SCHEMBL26166968 0.77 PTGES2 (0.44) KDM4EL3MBTL1CYP2C9PPARACYP1A2
SCHEMBL24510621 0.76 KDM4E (0.61) KDM4EL3MBTL1CYP2C9LMNAPPARA
SCHEMBL18322762 0.75 APP (0.44) CYP2C9SLC22A12CYP1A2CYP3A4
SCHEMBL14740848 0.74 CYP1A2 (0.45) KDM4EL3MBTL1LMNAPPARASLC22A12
SCHEMBL4457891 0.74 BLM (0.47) KDM4EL3MBTL1CYP2C9PPARACYP1A2
SCHEMBL7840765 0.74 PPARA (0.53) KDM4EL3MBTL1CYP2C9PPARACYP1A2
SCHEMBL13644181 0.74 KDM4E (0.70) KDM4ECYP2C9LMNACYP1A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833662-B1 INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION JANSSEN PHARMACEUTICA NV (BE) 2024-01-17 — — EP disclosed
CN-115151538-A Macrocyclic compounds, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2022-10-04 — — CN disclosed
Send feedback